RNA quality control and environmental stress
RNA质量控制和环境压力
基本信息
- 批准号:7431614
- 负责人:
- 金额:$ 39.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAutoimmune DiseasesBacteriaBindingBiological ProcessCell LineCell NucleusCell SurvivalCell physiologyCellsComplexCytoplasmDiseaseEubacteriumExonucleaseExoribonucleasesFailureGoalsImmune responseMammalian CellMusNuclearPathway interactionsPatientsPlayPolyribonucleotide NucleotidyltransferaseProcessProtein BindingProteinsQuality ControlRNARNA DegradationRNA HelicaseRNA-Binding ProteinsRibonucleasesRoleSS-A antigenScaffolding ProteinSmall RNAStressSystemic Lupus ErythematosusTestingXenopus oocytedisulfide bondinsightirradiationnovelprotein misfoldingrepairedultraviolet irradiation
项目摘要
DESCRIPTION (provided by applicant): The long term goals of this project are to understand how misfolded RNAs are recognized and handled within cells and to investigate how RNA misfolding impacts cell function. Our focus is on the Ro autoantigen, an RNA-binding protein that is a major target of the immune response in patients with systemic lupus erythematosus. In the cytoplasm of many animal cells, Ro binds small RNAs called Y RNAs. Although the function of the Ro/Y RNA complex has been enigmatic, we recently demonstrated that Ro has 2 conserved cellular functions. First, Ro binds misfolded, defective small RNAs in vertebrate cell nuclei, and thus likely plays a role in small RNA quality control. Second, Ro is part of a novel pathway by which mammalian cells and at least one eubacterium survive ultraviolet irradiation. Consistent with a role in the recognition or repair of nuclear damage, Ro accumulates in nuclei following irradiation. Most surprisingly, mice lacking Ro develop an autoimmune disease that resembles systemic lupus erythematosus in patients. These findings suggest that this putative RNA quality control pathway may be important for protecting cells from environmental stress and raise the possibility that failure of RNA quality control may result in disease. Our goal is to arrive at a mechanistic understanding of Ro function and to uncover the role that Y RNAs play in these processes. Our first aim is to determine how Ro recognizes misfolded RNAs and to investigate whether binding by Ro targets them for degradation. Our second aim is to elucidate the mechanism by which Ro facilitates mammalian and bacterial cell survival following ultraviolet irradiation. Our third aim is to examine the role of the Y RNAs in small RNA quality control and cell survival after irradiation. As Ro is the only protein described to bind misfolded small RNAs in cells, a study of its function should provide insights into a little-studied but highly important biological process.
描述(由申请人提供):该项目的长期目标是了解如何在细胞中识别和处理错误折叠的RNA,并研究RNA错误折叠如何影响细胞功能。我们的重点是RO Autoantigen,这是一种RNA结合蛋白,是全身性红斑狼疮患者免疫反应的主要靶标。在许多动物细胞的细胞质中,RO结合了称为Y RNA的小RNA。尽管RO/Y RNA复合物的功能是神秘的,但我们最近证明RO具有2个保守的细胞功能。首先,RO在脊椎动物细胞核中结合错误折叠的小RNA缺陷,因此很可能在小的RNA质量控制中起作用。其次,RO是一种新的途径的一部分,哺乳动物细胞和至少一个卵细菌在紫外线照射下生存。与识别或修复核损伤的作用一致,RO在照射后积累了核。最令人惊讶的是,缺乏RO的小鼠会形成一种自身免疫性疾病,类似于患者的全身性红斑狼疮。这些发现表明,这种假定的RNA质量控制途径对于保护细胞免受环境压力可能很重要,并增加了RNA质量控制失败可能导致疾病的可能性。我们的目标是对RO功能有一种机械理解,并揭示Y RNA在这些过程中所扮演的角色。我们的第一个目的是确定RO如何识别错误折叠的RNA,并调查RO的结合是否靶向降解。我们的第二个目的是阐明紫外线照射后RO促进哺乳动物和细菌细胞存活的机制。我们的第三个目的是检查Y RNA在照射后的小RNA质量控制和细胞存活中的作用。由于RO是唯一结合细胞中错误折叠的小RNA的蛋白质,因此对其功能的研究应提供深入的见解,以了解一些研究略有研究但非常重要的生物学过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sandra L. Wolin其他文献
Sandra L. Wolin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sandra L. Wolin', 18)}}的其他基金
Recruitment of host noncoding RNAs by HIV-1
HIV-1 招募宿主非编码 RNA
- 批准号:
8846742 - 财政年份:2015
- 资助金额:
$ 39.92万 - 项目类别:
Recruitment of host noncoding RNAs by HIV-1
HIV-1 招募宿主非编码 RNA
- 批准号:
9095216 - 财政年份:2015
- 资助金额:
$ 39.92万 - 项目类别:
Recruitment of host noncoding RNAs by XMRV
通过 XMRV 招募宿主非编码 RNA
- 批准号:
8223158 - 财政年份:2011
- 资助金额:
$ 39.92万 - 项目类别:
Recruitment of host noncoding RNAs by XMRV
通过 XMRV 招募宿主非编码 RNA
- 批准号:
8090165 - 财政年份:2011
- 资助金额:
$ 39.92万 - 项目类别:
Antibodies to Ro ribonucleoproteins as biomarkers in Sjogren's syndrome
Ro 核糖核蛋白抗体作为干燥综合征的生物标志物
- 批准号:
7268121 - 财政年份:2006
- 资助金额:
$ 39.92万 - 项目类别:
Antibodies to Ro ribonucleoproteins as biomarkers in Sjogren's syndrome
Ro 核糖核蛋白抗体作为干燥综合征的生物标志物
- 批准号:
7124973 - 财政年份:2006
- 资助金额:
$ 39.92万 - 项目类别:
相似国自然基金
索拉非尼通过诱导调节性T细胞抑制自身免疫性疾病的研究
- 批准号:32370955
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病相关因子VGLL3调控DNA损伤应答与肿瘤免疫微环境重塑研究
- 批准号:82341006
- 批准年份:2023
- 资助金额:150 万元
- 项目类别:专项基金项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
MALDI质谱分析用于自身免疫性疾病的快速诊断筛查
- 批准号:22274160
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
核苷酸转移酶cGAS乙酰化修饰抑制剂的设计、合成及抗自身免疫性疾病的机制研究
- 批准号:82273767
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Mining host-microbe interactions in the neonatal pancreas to combat diabetes
挖掘新生儿胰腺中宿主-微生物的相互作用来对抗糖尿病
- 批准号:
10664448 - 财政年份:2023
- 资助金额:
$ 39.92万 - 项目类别:
Biasing immunological development with early life microbial colonization
生命早期微生物定植导致免疫发育偏向
- 批准号:
10730933 - 财政年份:2023
- 资助金额:
$ 39.92万 - 项目类别:
Immunological Basis of Autoimmune Addison's Disease in a Novel Canine Model System
新型犬模型系统中自身免疫阿狄森氏病的免疫学基础
- 批准号:
10830527 - 财政年份:2023
- 资助金额:
$ 39.92万 - 项目类别:
Identification of antimicrobial specialized metabolites from the human oral microbiome to target multidrug-resistant pathogens
从人类口腔微生物组中鉴定抗菌专门代谢物以靶向多重耐药病原体
- 批准号:
10605700 - 财政年份:2023
- 资助金额:
$ 39.92万 - 项目类别:
Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome
自身抗体作为治疗后莱姆病综合征的预测标记
- 批准号:
10737996 - 财政年份:2023
- 资助金额:
$ 39.92万 - 项目类别: